| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/17/2002 | US20020006932 Central nervous system disorders; heeadaches, antiinflammatory agents |
| 01/17/2002 | US20020006929 Antiarrhythmia agent, antiproliferative agent |
| 01/17/2002 | US20020006923 Thrombin inhibitors |
| 01/17/2002 | US20020006917 Method of locking 1alpha-OH of vitamin D compounds in axial orientation |
| 01/17/2002 | US20020006903 Genetic engineering |
| 01/17/2002 | US20020006901 Prevent grafting rejection |
| 01/17/2002 | US20020006640 Uteroglobin-like polynucleotides, polypeptides, and antibodies |
| 01/17/2002 | US20020006432 Bifidobacterium in the treatment of inflammatory disease |
| 01/17/2002 | US20020006413 Stimulating an immune response in a patient having an adenocarcinoma, comprising administering to such patient one or more allogenic tumor cells selected from SW620 cell, COLO 205 cell, and SW403 cell |
| 01/17/2002 | US20020006410 Method for treating inflammatory diseases using heat shock proteins |
| 01/17/2002 | US20020006407 Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability |
| 01/17/2002 | US20020006392 Isolating peripheral mononuclear blood cells from a recipient and a donor; mixing donor and recipient cells ex vivo, treating the cells with a regulatory composition (TGF-beta) transforming growth factor to activate the cells |
| 01/17/2002 | US20020006391 Genetic engineering |
| 01/17/2002 | US20020006381 Method for finding nucleotide synthesis inhibitors having fewer side effects |
| 01/17/2002 | DE10032538A1 Vakzine gegen Helicobacter pylori Vaccine against Helicobacter pylori |
| 01/17/2002 | DE10005302A1 Substituierte 1,2,3,4-Tetrahydrochinolin-2-carbonsäurederivate Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives |
| 01/17/2002 | CA2415808A1 Transporters and ion channels |
| 01/17/2002 | CA2415544A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/17/2002 | CA2415492A1 Pyrazole derivatives |
| 01/17/2002 | CA2415434A1 Use of the heat shock protein gp96 |
| 01/17/2002 | CA2414387A1 Drug metabolizing enzymes |
| 01/17/2002 | CA2414219A1 Lipid metabolism molecules |
| 01/17/2002 | CA2413810A1 Aminoacyl trna synthetases |
| 01/17/2002 | CA2412162A1 Chemokine receptor modulators, production and use |
| 01/17/2002 | CA2412150A1 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use |
| 01/17/2002 | CA2411160A1 Colchinol derivatives as vascular damaging agents |
| 01/16/2002 | EP1172376A1 Peptide analogues at position 91 of human myelin basic protein for treatment of multiple sclerosis |
| 01/16/2002 | EP1172359A1 N-SUBSTITUTED-N'-SUBSTITUTED UREA DERIVATIVE AND USE THEREOF AS TNF-$g(a) PRODUCTION INHIBITOR |
| 01/16/2002 | EP1172111A1 Pharmaceutical composition with adhesion molecule expression regulating activity |
| 01/16/2002 | EP1172109A1 Compositions for preventing and treating type i allergy |
| 01/16/2002 | EP1172108A1 Novel immunosuppressants |
| 01/16/2002 | EP1172106A2 Use of fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles as substance P receptor antagonists |
| 01/16/2002 | EP1171629A1 Novel essential bacterial genes and their proteins |
| 01/16/2002 | EP1171626A1 50 human secreted proteins |
| 01/16/2002 | EP1171614A1 Dsp-4 dual-specificity map kinase phosphatase |
| 01/16/2002 | EP1171613A1 Dsp-7 dual-specificity map kinase phosphatase |
| 01/16/2002 | EP1171608A2 Recombinant and mutant marek's disease virus |
| 01/16/2002 | EP1171604A2 Dna sequence and recombinant production of a graminae allergen |
| 01/16/2002 | EP1171596A1 Synthetic transmembrane components |
| 01/16/2002 | EP1171591A1 48 human secreted proteins |
| 01/16/2002 | EP1171590A1 50 human secreted proteins |
| 01/16/2002 | EP1171587A1 Peptide from antigen muc-1 for triggering an immune response to tumor cells |
| 01/16/2002 | EP1171585A1 49 human secreted proteins |
| 01/16/2002 | EP1171583A2 A multi-plasmid method for preparing large libraries of polyketides and non-ribosomal peptides |
| 01/16/2002 | EP1171579A1 Human tumor necrosis factor receptor tr9 |
| 01/16/2002 | EP1171469A1 ANTI-p53 ANTIBODIES |
| 01/16/2002 | EP1171464A2 Peptide homodimers or peptide heterodimers derived from interleukin 12 |
| 01/16/2002 | EP1171463A2 Peptide homodimers and peptide heterodimers, derived from interferon alpha 2 |
| 01/16/2002 | EP1171462A2 49 human secreted proteins |
| 01/16/2002 | EP1171457A1 46 human secreted proteins |
| 01/16/2002 | EP1171442A1 Xanthine derivatives and analogs as cell signalling inhibitors |
| 01/16/2002 | EP1171441A1 Morphinoid compounds |
| 01/16/2002 | EP1171432A1 Adamantane derivatives |
| 01/16/2002 | EP1171425A1 Use of maduraphthalazine derivatives as inhibitors of pro-inflammatory cytokins |
| 01/16/2002 | EP1171419A1 Biphenyl derivatives as antagonists of the neurokinine-1 receptor |
| 01/16/2002 | EP1171160A1 Method and means for treating post-polio syndrome |
| 01/16/2002 | EP1171159A2 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv) |
| 01/16/2002 | EP1171154A2 Uses of mammalian ox2 protein and related reagents |
| 01/16/2002 | EP1171149A1 Inhibition of proteasome function induces programmed cell death in endothelial cells |
| 01/16/2002 | EP1171140A2 Treatment of hypersensitivity reaction disorders |
| 01/16/2002 | EP1171136A2 Immunomodulating composition for use especially in the treatment of inflammations, infections and surgical adhesions |
| 01/16/2002 | EP1171131A1 Medicaments containing inhibitors of cell-volume regulated human kinase h-sgk |
| 01/16/2002 | EP1171127A2 Pharmaceutical compositions containing pyridine or pyrimidine derivatives for inhibition of cytokine production and secretion |
| 01/16/2002 | EP1171125A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 01/16/2002 | EP1171122A1 Pyrrolidine modulators of chemokine receptor activity |
| 01/16/2002 | EP1171115A1 Methods of delivery of cetyl myristoleate |
| 01/16/2002 | EP1171113A1 Compounds useful as phosphotyrosine mimics |
| 01/16/2002 | EP1171109A1 Compositions containing immunotoxins and agents that inhibit dendritic cell maturation for inducing immune tolerance to a graft |
| 01/16/2002 | EP1093374B1 Hypo-osmotic saline solutions, method for preparing same and medicines based on said solutions |
| 01/16/2002 | EP1007067B1 Pharmaceutical compositions containing parthenium integrifolium or parts thereof or an extract or component thereof, the use of such plant material for preparing certain medicines, and a method of preparing an extract of parthenium integrifolium |
| 01/16/2002 | EP0896585B1 Humanized anti-cd40 monoclonal antibodies and fragments capable of blocking b cell activation |
| 01/16/2002 | EP0866701B1 Synergistic immunosuppressant composition containing a 2,2'-bi-1h-pyrrole compound |
| 01/16/2002 | EP0859626B1 Pharmaceutical preparation containing cyclosporin(s) for oral administration and process for producing the said preparation |
| 01/16/2002 | EP0811071B1 Amplifier sequences derived from the desmin gene, vectors comprising same and uses thereof for producing proteins |
| 01/16/2002 | EP0697875B1 Use of modified tall-104 cells to treat cancer and viral diseases |
| 01/16/2002 | CN1331701A Modified peptides as therapeutic agents |
| 01/16/2002 | CN1331698A Brain cell or nerve cell-protective agents comprising ginsenoside Rb1 |
| 01/16/2002 | CN1331694A Antihistaminic spiro compounds |
| 01/16/2002 | CN1331688A Aminopyrazole derivatives |
| 01/16/2002 | CN1331683A 2-phenylbenzimidazoles and 2-phenylindoles, and prodn. and use thereof |
| 01/16/2002 | CN1331682A Substituted 2-phenylbenzimidazoles, prodn. thereof and their use |
| 01/16/2002 | CN1331679A 3-azabicyclo [3.1.0] hexane derivatives as opiate receptors ligands |
| 01/16/2002 | CN1331603A Tolerance to xenograft |
| 01/16/2002 | CN1331602A Methods of downmodulating immune response to therapeutic proteins |
| 01/16/2002 | CN1331308A Polypeptide-human I kappa B kinase 15 and polynucleotide for coding it |
| 01/16/2002 | CN1331218A Polypeptide-human zinc finger protein 12.98 and polynucleotide for coding it |
| 01/16/2002 | CN1331217A Polypeptide-human EHD protein 9.57 and polynucleotide for coding it |
| 01/16/2002 | CN1331174A Polypeptide-human Zinc finger protein 10.45 and polynucleotide for coding it |
| 01/16/2002 | CN1331163A Polypeptide-human transcription regulator factor 2FM1 isomer 19.47 and polynucleotide for coding it |
| 01/16/2002 | CN1331119A Polypeptide-human FK506 bindin 13.42 and polynucleotide for coding it |
| 01/16/2002 | CN1330950A Chinese medicine for optimally taking care of brain health |
| 01/16/2002 | CN1077886C Amidino derivatives useful as nitric oxide synthase inhibitors |
| 01/16/2002 | CN1077800C Cyclosporin soft capsule compsn. |
| 01/15/2002 | US6339149 Isolated nucleic acid molecules which encode tumor rejection antigens found in dage |
| 01/15/2002 | US6339101 Administering n-linked sulfonamide of an n-heterocyclic carboxylic acid derivative for therapy of nerve-related vision disorder, improving vision, therapy memory impairment or enhancing memory performance in an animal |
| 01/15/2002 | US6339094 2-acylaminopropanamines as tachykinin receptor antagonists |
| 01/15/2002 | US6338952 Stress proteins and uses therefor |
| 01/15/2002 | US6338851 Method of suppressing an immune response to a transplanted organ or tissue by administering an OX-2 protein |
| 01/15/2002 | US6338850 Administering immunosuppressive dosage of plant tissue and purification |
| 01/15/2002 | US6338849 Process of preparing immunoglobulin for intravenous injection by viruses double-sterilized without adding any protectant |